People with alopecia areata have more inflammation but similar heart risk as healthy people.
April 2025 in “American Journal of Case Reports” Improper use of minoxidil can cause excessive hair growth.
March 2025 in “Journal of the American Academy of Dermatology” Systemic minoxidil improves hair density in women with female pattern hair loss over time.
Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.
Alopecia areata is more common in males, often appears as patchy hair loss, and is strongly linked to anemia.
February 2025 in “Indian Dermatology Online Journal” Pincer nails are rare in lupus patients and may be managed conservatively.
November 2024 in “Indian Journal of Rheumatology” Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.
November 2024 in “Journal of the European Academy of Dermatology and Venereology” More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.
November 2024 in “International Society of Hair Restoration Surgery” Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.
October 2024 in “American Journal of Case Reports” Baricitinib improved hair loss and arthritis in a lupus patient.
October 2024 in “Journal of Case Reports in Medical Science” Psychiatric symptoms can be early signs of systemic lupus erythematosus.
October 2024 in “Heliyon” Consider systemic lupus erythematosus in patients with unexplained intracranial hypertension.
September 2024 in “Journal of the American Academy of Dermatology” PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.
August 2024 in “Indian Journal of Dermatology Venereology and Leprology” July 2024 in “Journal of Investigative Dermatology” Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.
July 2024 in “Journal of Investigative Dermatology” A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.
July 2024 in “Indonesian Journal of Case Reports” Effective treatment improved skin and overall symptoms in a lupus patient.
Anifrolumab improves quality of life and reduces steroid use in lupus patients.
A high fat lard diet may protect against skin fibrosis and affect hair growth.
Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.
May 2024 in “International journal of medicine and psychology.” Depression worsens eczema severity, increases inflammation, and lowers quality of life.
Hair chemicals don't cause SLE but may increase skin issues in those with SLE.
April 2024 in “African Journal of Biological Sciences” The treatment led to significant hair regrowth in a lupus patient.
April 2024 in “African Journal of Biological Sciences” The patient with lupus and Degos' disease showed significant improvement with treatment.
March 2024 in “Clinical, cosmetic and investigational dermatology” Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.
February 2024 in “Internet Journal of Rheumatology and Clinical Immunology” A rare case of lupus linked to thymoma shows complex diagnosis and management challenges.
February 2024 in “Animals” Most dogs with adrenal-dependent hypercortisolism had normal blood pressure after one year of treatment or surgery.
February 2024 in “Rheumatology & autoimmunity” Lupus can cause unusual vision problems, so it's important to consider it in such cases.
January 2024 in “Pan African Medical Journal” Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.
January 2024 in “Dermatologic therapy” Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.